Adenoviral vector platform for transduction of constitutive and regulated tricistronic or triple-transcript transgene expression in mammalian cells and microtissues

Journal of Gene Medicine

Volumn 8, Issue 10, 2006, Pages 1208-1222

  Gonzalez Nicolini, Valeria ^a   Diaz Sanchez Bustamante, Carlota ^a   Hartenbach, Shizuka ^a   Fussenegger, Martin ^a  

^a ETH ZURICH   (Switzerland)

Author keywords

Adenovirus; Gene switch; Multicistronic expression; PIP; Pristinamyclin; SAMY; SEAP; Streptogramin; VEGF

Indexed keywords

AMYLASE VASCULOTROPHIN 121 ALKALINE PHOSPHATASE PLACENTA ISOENZYME FUSION PROTEIN; HYBRID PROTEIN; PRISTINAMYCIN; STREPTOGRAMIN; UNCLASSIFIED DRUG;

ADENOVIRUS VECTOR; ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CELL SPECIFICITY; CELL STRAIN HEK293; CELL TYPE; CHO CELL; CISTRON; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA PACKAGING; EXPRESSION VECTOR; FIBROBLAST CULTURE; GENE EXPRESSION REGULATION; GENE EXPRESSION SYSTEM; GENE TARGETING; GENETIC TRANSDUCTION; GEOBACILLUS STEAROTHERMOPHILUS; HEART MUSCLE CELL; HUMAN; HUMAN CELL; INTERNAL RIBOSOME ENTRY SITE; MONOLAYER CULTURE; MULTIGENE FAMILY; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; RAT; SIMIAN VIRUS 40; TRANSCRIPTION REGULATION; TRANSGENE; TRANSLATION INITIATION; TRANSLATION REGULATION; TRICISTRONIC EXPRESSION VECTOR; TRIPLE TRANSCRIPT EXPRESSION VECTOR; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY; VIRUS PARTICLE; VIRUS RECOMBINANT;

ADENOVIRIDAE; ANIMALS; CELLS, CULTURED; CHO CELLS; CRICETINAE; GENE EXPRESSION REGULATION; GENES; GENETIC ENGINEERING; GENETIC VECTORS; HUMANS; RATS; RECOMBINANT PROTEINS; REGULON; STREPTOGRAMINS; TRANSDUCTION, GENETIC; TRANSGENES;

ADENOVIRIDAE; CRICETULUS GRISEUS; GEOBACILLUS STEAROTHERMOPHILUS; HUMAN HERPESVIRUS 5; MAMMALIA; MURINAE; SIMIAN VIRUS 40;

EID: 33750502651     PISSN: 1099498X     EISSN: 15212254     Source Type: Journal    
DOI: 10.1002/jgm.960     Document Type: Article

References (41)

1. Massie B, Couture F, Lamoureux L, et al. Inducible overexpression of a toxic protein by an adenovirus vector with a tetracycline-regulatable expression cassette. J Virol. 1998; 72: 2289-2296.
2. Ogorelkova M, Elahi SM, Gagnon D, Massie B. DNA delivery to cells in culture: generation of adenoviral libraries for high-throughput functional screening. Methods Mol Biol 2004; 246: 15-27.
3. Dougherty JP, Temin HM. A promoter-less retroviral vector indicates that there are sequences in U3 required for 3′ RNA processing. Proc Natl Acad Sci U S A 1987; 84: 1197-1201.
4. Emerman M, Temin HM. Genes with promoters in retrovirus vectors can be independently suppressed by an epigenetic mechanism. Cell 1984; 39: 449-467.
5. Koo HM, Brown AM, Kaufman RJ, Prorock CM, Ron Y, Dougherty JP. A spleen necrosis virus-based retroviral vector which expresses two genes from a dicistronic mRNA. Virology 1992;186:669-675.
6. Morgan RA, Couture L, Elroy-Stein O, Ragheb J, Moss B, Anderson WF. Retroviral vectors containing putative internal ribosome entry sites: development of a polycistronic gene transfer system and applications to human gene therapy. Nucleic Acids Res 1992; 20: 1293-1299.
7. Weber W, Fussenegger M. Approaches for trigger-inducible viral transgene regulation in gene-based tissue engineering. Curr Opin Biotechnol 2004; 15: 383-391.
8. Gonzalez-Nicolini V, Fussenegger M. A novel binary adenovirus-based dual-regulated expression system for independent transcription control of two different transgenes. J Gene Med 2005; 7: 1573-1585.
9. Kelm JM, Timmins NE, Brown CJ, Fussenegger M, Nielsen LK. Method for generation of homogeneous multicellular tumor spheroids applicable to a wide variety of cell types. Biotechnol Bioeng 2003; 83: 173-180.
10. Kelm JM, Ehler E, Nielsen LK, Schlatter S, Perriard JC, Fussenegger M. Design of artificial myocardial microtissues. Tissue Eng 2004; 10: 201-214.
11. Kelm JM, Fussenegger M. Microscale tissue engineering using gravity-enforced cell assembly. Trends Biotechnol 2004; 22: 195-202.
12. Kelm JM, Diaz Sanchez-Bustamante C, Ehler E, et al. VEGF profiling and angiogenesis in human microtissues. J Biotechnol 2005; 118: 213-229.
13. Kelm JM, Ittner LM, Born W, Djonov V, Fussenegger M. Self-assembly of sensory neurons into ganglia-like microtissues. J Biotechnol 2006; 121: 86-101.
14. Sanchez-Bustamante CD, Kelm JM, Mitta B, Fussenegger M. Heterologous protein production capacity of mammalian cells cultivated as monolayers and microtissues. Biotechnol Bioeng 2006; 93: 169-180.
15. Link N, Aubel C, Kelm JM, et al. Therapeutic protein transduction of mammalian cells and mice by nucleic acid-free lentiviral nanoparticles. Nucleic Acids Res 2006; 34: e16.
16. Danthinne X, Imperiale MJ. Production of first generation adenovirus vectors: a review. Gene Ther 2000; 7: 1707-1714.
17. Russell WC. Update on adenovirus and its vectors. J Gen Virol 2000; 81: 2573-2604.
18. Lusky M, Christ M, Rittner K, et al. In vitro and in vivo biology of recombinant adenovirus vectors with E1, E1/E2A, or E1/E4 deleted. J Virol 1998; 72: 2022-2032.
19. Yeh P, Dedieu JF, Orsini C, Vigne E, Denefle P, Perricaudet M. Efficient dual transcomplementation of adenovirus E1 and E4 regions from a 293-derived cell line expressing a minimal E4 functional unit. J Virol 1996; 70: 559-565.
20. Parks RJ, Chen L, Anton M, Sankar U, Rudnicki MA, Graham FL. A helper-dependent adenovirus vector system: removal of helper virus by Cre-mediated excision of the viral packaging signal. Proc Natl Acad Sci U S A 1996; 93: 13565-13570.
21. Rothen-Ruthishauser BM, Ehler E, Perriard E, Messerli JM, Perriard JC. Different behaviour of the non-sarcomeric cytoskeleton in neonatal and adult rat cardiomyocytes. J Mol Cell Cardiol 1998; 30: 19-31.
22. Nyberg-Hoffman C, Shabram P, Li W, Giroux D, Aguilar-Cordova E. Sensitivity and reproducibility in adenoviral infectious titer determination. Nat Med 1997; 3: 808-811.
23. Dion LD, Fang J, Garver RI Jr. Supernatant rescue assay vs. polymerase chain reaction for detection of wild type adenovirus-contaminating recombinant adenovirus stocks. J Virol Methods 1996; 56: 99-107.
24. Berger J, Hauber J, Hauber R, Geiger R, Cullen BR. Secreted placental alkaline phosphatase: a powerful new quantitative indicator of gene expression in eukaryotic cells. Gene 1988; 66: 1-10.
25. Schlatter S, Rimann M, Kelm J, Fussenegger M. SAMY, a novel mammalian reporter gene derived from Bacillus stearothermophilus alpha-amylase. Gene 2002; 282: 19-31.
26. Kramer BP, Fussenegger M. Hysteresis in a synthetic mammalian gene network. Proc Natl Acad Sci U S A 2005; 102: 9517-9522.
27. Fussenegger M, Mazur X, Bailey JE. pTRIDENT, a novel vector family for tricistronic gene expression in mammalian cells. Biotechnol Bioeng 1998; 57: 1-10.
28. Moser S, Schlatter S, Fux C, Rimann M, Bailey JE, Fussenegget M. An update of pTRIDENT multicistronic expression vectors: pTRIDENTs containing novel streptogramin-responsive promoters. Biotechnol Prog 2000; 16: 724-735.
29. Weber W, Marty RR, Keller B, Rimann M, Kramer BP, Fussenegger M. Versatile macrolide-responsive mammalian expression vectors for multiregulated multigene metabolic engineering. Biotechnol Bioeng 2002; 80: 691-705.
30. Mitta B, Rimann M, Ehrengruber MU, et al. Advanced modular self-inactivating lentiviral expression vectors for multigene interventions in mammalian cells and in vivo transduction. Nucleic Acids Res 2002; 30: e113.
31. Fux C, Langer D, Kelm JM, Weber W, Fussenegger M. New-generation multicistronic expression platform: pTRIDENT vectors containing size-optimized IRES elements enable homing endonuclease-based cistron swapping into lentiviral expression vectors. Biotechnol Bioeng 2004; 86: 174-187.
32. Hartenbach S, Fussenegger M. Autoregulated, bidirectional and multicistronic gas-inducible mammalian as well as lentiviral expression vectors. J Biotechnol 2005; 120: 83-98.
33. Hartenbach S; Fussenegger M. Novel mammalian promoters derived from internal ribosome entry sites. J Biotechnol 2006; in press.
34. Rodriguez CR, Fei D, Keyt B, Baly DL. A sensitive fluorometric enzyme-linked immunosorbent assay that measures vascular endothelial growth factor165 in human plasma. J Inununol Methods 1998; 219: 45-55.
35. Fernandez-Miragall O, Ramos R, Ramajo J, Martinez-Salas E. Evidence of reciprocal tertiary interactions between conserved motifs involved in organizing RNA structure essential for internal initiation of translation. RNA 2006; 12: 223-234.
36. Reigadas S, Pacheco A, Ramajo J, de Quinto SL, Martinez-Salas E. Specific interference between two unrelated internal ribosome entry site elements impairs translation efficiency. FEBS Lett 2005; 579: 6803-6808.
37. Fussenegger M, Morris RP, Fux C, et al. Streptogramin-based gene regulation systems for mammalian cells. Nat Biotechnol 2000; 18: 1203-1208.
38. Addison CL, Hitt M, Kunsken D, Graham FL. Comparison of the human versus murine cytomegalovirus immediate early gene promoters for transgene expression by adenoviral vectors. J Gen Virol 1997; 78: 1653-1661.
39. Sallenave JM, Xing Z, Simpson AJ, Graham FL, Gauldie J. Adenovirus-mediated expression of an elastase-specific inhibitor (elafin): a comparison of different promoters. Gene Ther 1998; 5:352-360.
40. Folcher M, Morris RP, Dale G, Salah-Bey-Hocini K, Viollier PH, Thompson CJ. A transcriptional regulator of a pristinamycin resistance gene in Streptomyces coelicolor. J Biol Chem 2001; 276: 1479-1485.
41. Alba R, Bosch A, Chillon M. Gutless adenovirus: last-generation adenovirus for gene therapy. Gene Ther 2005; 12: S18-27.